PET may be diagnostically more powerful than ultrasound or CT for identifying early coronary artery disease in patients with type 2 diabetes.
PET may be diagnostically more powerful than ultrasound or CT for identifying early coronary artery disease in patients with type 2 diabetes.
Nuclear cardiologist Dr. Thomas Schindler and colleagues at the University of Geneva in Switzerland and the University of California, Los Angeles measured coronary endothelium dysfunction with nitrogen-13 ammonia PET and rest-stress PET.
They found diabetes patients with normal or elevated blood pressure showed significantly stronger signs of vascular disease than did normal controls. They also compared PET with high-resolution vascular ultrasound and multislice CT coronary calcium tests and found PET more sensitive than either sonography or CT. Results were presented at the 2008 SNM meeting.
Study: AI Boosts Ultrasound AUC for Predicting Thyroid Malignancy Risk by 34 Percent Over TI-RADS
February 17th 2025In a study involving assessment of over 1,000 thyroid nodules, researchers found the machine learning model led to substantial increases in sensitivity and specificity for estimating the risk of thyroid malignancy over traditional TI-RADS and guidelines from the American Thyroid Association.
Can CT-Based AI Provide Automated Detection of Colorectal Cancer?
February 14th 2025For the assessment of contrast-enhanced abdominopelvic CT exams, an artificial intelligence model demonstrated equivalent or better sensitivity than radiologist readers, and greater than 90 percent specificity for the diagnosis of colorectal cancer.
Emerging PET/CT Agent Shows Promise in Detecting PCa Recurrence in Patients with Low PSA Levels
February 13th 202518F-DCFPyL facilitated detection of recurrent prostate cancer in 51 percent of patients with PSA levels ranging between 0.2 to 0.5 ng/ml, according to new research presented at the American Society of Clinical Oncology Genitourinary Cancers (ASCO-GU) Symposium.